The highest level of agreement was reached for the lack of somatostatin receptors on adenoma and genetic predisposition as characteristic predicting resistance to fgSRLs (96% and 92%, respectively), and for IGF-1 levels being central for evaluating resistance (89% agreement). This evidence concerns the gene IGF1 and adenoma.